Search Results

Approach to Acute Intermediate-Risk Pulmonary Embolism

Moderator: Geoffrey D. Barnes, MD, MSc,
Panelists: Michael McDaniel, MD, FACC, FSCAI, and Frances Mae West, MD, MS, FACP

Pulmonary Embolism Risk Stratification: Progress, Gaps, and the Path Forward

Key developments, lessons learned, where current tools fall short, and what’s in the pipeline.

By Frances Mae West, MD, MSc, FACP; Thomas M. Todoran, MD, MSc; Andrew J. P. Klein, MD; and James Horowitz, MD

The Progression of Decision-Making for PE Treatment: A Pulmonologist’s Evidence-Based Perspective

From thrombolytics hesitancy to the development of catheter-based thrombolysis and embolectomy, a pulmonologist shares her perspective on the history of PE care decisions and its supportive evidence over the years.

By Frances Mae West, MD, MS, FACP

Ask The Experts: What Does PE Intervention Look Like in 2034?

Experts consider the role of PERTs, technologic advances, and the state of research and data in the next 10 years.

With Brent Keeling, MD; Robert A. Lookstein, MD, MHCDL, FSIR, FAHA, FSVM; Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM; and Frances Mae West, MD, MS, FACP

Pulmonary Embolism Interventions

By Akhilesh K. Sista, MD, FSIR, FAHA

Advancing PE Management

By Kenneth Rosenfield, MD, MHCDS

Exploring the Why: Pivotal Case-Based Decisions

By Leigh Ann O’Banion, MD

Improving Trial Design

Mark H. Wholey, MD, explains why patient selection and operator experience remain critical to CAS studies and the future of the procedure.

By Mark H. Wholey, MD